Increased CYP4B1 mRNA is associated with the inhibition of dextran sulfate sodium-induced colitis by caffeic acid in mice

Experimental Biology and Medicine

Volumn 234, Issue 6, 2009, Pages 606-616

  Ye, Zhong ^a   Liu, Zhiping ^a   Henderson, Abigail ^a   Lee, Kwangwon ^b   Hostetter, Jesse ^a   Wannemuehler, Michael ^a   Hendrich, Suzanne ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b Korea University   (South Korea)

Author keywords

Caffeic acid; Colitis; CYP4B1; Inflammation; Mouse; Rutin

Indexed keywords

CAFFEIC ACID; CYTOCHROME P450 4B1; DEXTRAN SULFATE; DRINKING WATER; HYPOXOSIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; INTERLEUKIN 4; MESSENGER RNA; MYELOPEROXIDASE; PHENOL DERIVATIVE; RUTOSIDE; UNCLASSIFIED DRUG; ALKYNE; ANTIOXIDANT; CAFFEIC ACID DERIVATIVE; CYTOCHROME P 450 CYP4B1; CYTOCHROME P-450 CYP4B1; GLUCOSIDE; NOS2 PROTEIN, MOUSE; PEROXIDASE; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CECUM; CELL INFILTRATION; COLITIS; COLON; CONTROLLED STUDY; EDEMA; EROSION; FEMALE; FOOD INTAKE; GENE EXPRESSION; HISTOPATHOLOGY; INFLAMMATORY CELL; INTESTINE INJURY; MALE; MOUSE; MUCOSA; NECROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTECTION; UPREGULATION; WEIGHT REDUCTION; ANIMAL; BIOSYNTHESIS; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EATING; ENTERITIS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ORGAN SIZE; PATHOLOGY; TIME;

MUS;

ALKYNES; ANIMALS; ANTIOXIDANTS; ARYL HYDROCARBON HYDROXYLASES; BODY WEIGHT; CAFFEIC ACIDS; COLITIS; COLON; DEXTRAN SULFATE; EATING; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSIDES; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-17; INTERLEUKIN-4; MALE; MICE; NITRIC OXIDE SYNTHASE TYPE II; ORGAN SIZE; PEROXIDASE; RNA, MESSENGER; RUTIN; TIME FACTORS;

EID: 66449112764     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0901-RM-1     Document Type: Article

References (55)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 47:417-429, 2002.
2. Shah S. Dietary factors in the modulation of inflammatory bowel disease activity. MedGenMed 9:60, 2007. (Pubitemid 46504821)
3. Mellemkjaer L, Olsen JH, Frisch M, Johansen C, Gridley G, McLaughlin JK. Cancer in patients with ulcerative colitis. Int J Cancer 60:330-333, 1995.
4. Hutto DL, Galvin JE, Wannemuehler MJ. Morphological and temporal characterisation of lesions in an enhanced model of Serpulina hyodysenteriae infection. J Med Microbiol 47:275-280, 1998. (Pubitemid 28090057)
5. Jergens AE, Wilson-Welder JH, Dorn A, Henderson A, Liu Z, Evans RB, Hostetter J, Wannemuehler MJ. Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice. Gut 56:934-940, 2007. (Pubitemid 46999076)
6. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SG, Van Rees EP. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 114:385-391, 1998. (Pubitemid 28539597)
7. Stevceva L, Pavli P, Buffinton G, Wozniak A, Doe WF. Dextran sodium sulphate-induced colitis activity varies with mouse strain but develops in lipopolysaccharide-unresponsive mice. J Gastroenterol Hepatol 14:54-60, 1999. (Pubitemid 29087318)
8. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 109:1344-1367, 1995.
9. Reed KL, Fruin AB, Gower AC, Gonzales KD, Stucchi AF, Andry CD, O'Brien M, Becker JM. NF-jB activation precedes increases in mRNA encoding neurokinin-1 receptor, proinflammatory cytokines, and adhesion molecules in DSS-induced colitis in rats. Dig Dis Sci 50: 2366-2378, 2005. (Pubitemid 43106398)
10. Podolsky DK. Inflammatory bowel disease (2). N Engl J Med 325: 1008-1016, 1991.
11. Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 120:622-635, 2001. (Pubitemid 32171636)
12. Fitzpatrick LR, Wang J, Le T. Caffeic acid phenethyl ester, an inhibitor of nuclear factor-kappaB, attenuates bacterial peptidoglycan polysac- charide-induced colitis in rats. J Pharmacol Exp Ther 299:915-920, 2001. (Pubitemid 33104959)
13. Kwon KH, Murakami A, Tanaka T. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem Pharmacol 69:395-406, 2005. (Pubitemid 40094500)
14. Bereta J, Bereta M, Allison AC, Kruger PB, Koj A. Inhibitory effect of di-catechol rooperol on VCAM-1 and iNOS expression in cytokine-stimulated endothelium. Life Sci 60:325-334, 1997. (Pubitemid 27037320)
15. Dietzsch E, Albrecht CF, Parker MI. Effect of rooperol on collagen synthesis and cell growth. IUBMB Life 48:321-325, 1999. (Pubitemid 29517387)
16. Kitajima S, Takuma S, Morimoto M. Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim 48:137-143, 1999. (Pubitemid 129558679)
17. Murakami A, Hayashi R, Tanaka T, Kwon KH, Ohigashi H, Safitri R. Suppression of dextran sodium sulfate-induced colitis in mice by zerumbone, a subtropical ginger sesquiterpene, and nimesulide: separately and in combination. Biochem Pharmacol 66:1253-1261, 2003. (Pubitemid 37130300)
18. Nibbelink SK, Wannemuehler MJ. An enhanced murine model for studies of Serpulina (Treponema) hyodysenteriae pathogenesis. Infect Immun 60:3433-3436, 1992.
19. Jergens AE, Dorn A, Wilson J, Dingbaum K, Henderson A, Liu Z, Hostetter J, Evans RB, Wannemuehler MJ. Induction of differential immune reactivity to members of the flora of gnotobiotic mice following colonization with Helicobacter bilis or Brachyspira hyodysenteriae. Microbes Infect 8:1602-1610, 2006. (Pubitemid 43903324)
20. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, Mathieu C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14:33-43, 2003.
21. Overbergh L, Valckx D, Waer M, Mathieu C. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305-312, 1999. (Pubitemid 29213178)
22. Xia Y, Zweier JL. Measurement of myeloperoxidase in leukocyte-containing tissues. Anal Biochem 245:93-96, 1997. (Pubitemid 27053423)
23. Palic D, Andreasen CB, Menzel BW, Roth JA. A rapid, direct assay to measure degranulation of primary granules in neutrophils from kidney of fathead minnow (Pimephales promelas Rafinesque, 1820) Fish and Shellfish. Immunology 19:217-227, 2005. (Pubitemid 40451895)
24. Clifford MN. Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden. J Sci Food Agric 79:362-372, 1999 (Pubitemid 29150578)
25. Radtke J, Linseisen J, Wolfram G. Phenolic acid intake of adults in a Bavarian subgroup of the national food composition survey. Z Ernahrungswiss 37:190-197, 1998. (Pubitemid 28318362)
26. Bobe G, Weinstein SJ, Albanes D, Hirvonen T, Ashby J, Taylor PR, Virtamo J, Stolzenberg-Solomon RZ. Flavonoid intake and risk of pancreatic cancer in male smokers (Finland). Cancer Epidemiol Biomarkers Prev 17:553-562, 2008.
27. Mayer L. IBD: immunological research at the Mount Sinai hospital. Mt Sinai J Med 67:208-213, 2000.
28. Shanahan F. Crohn's disease. Lancet 359:62-69, 2002. (Pubitemid 34119201)
29. Ciancio MJ, Chang EB. Epithelial secretory response to inflammation. Ann N Y Acad Sci 664:210-221, 1992. (Pubitemid 23022851)
30. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69:238-249, 1993. (Pubitemid 23262505)
31. Raso GM, Pacilio M, Di Carlo G, Esposito E, Pinto L, Meli R. In-vivo and in-vitro anti-inflammatory effect of Echinacea purpurea and Hypericum perforatum. J Pharm Pharmacol 10:1379-1383, 2002. (Pubitemid 35174184)
32. Ek RO, Serter M, Ergin K, Yildiz Y, Cecen S, Kavak T, Yenisey C. The effects of caffeic acid phenethyl ester (CAPE) on TNBS-induced colitis in ovariectomized rats. Dig Dis Sci 53:1609-1617, 2008.
33. Celik S, Gorur S, Aslantas O, Erdogan S, Ocak S, Hakverdi S. Caffeic acid phenethyl ester suppresses oxidative stress in Escherichia coli- induced pyelonephritis in rats. Mol Cell Biochem 297:131-138, 2007. (Pubitemid 46443537)
34. La Casa C, Villegas I, Alarcon de la Lastra C, Motilva V, Martin Calero MJ. Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions. J Ethnopharmacol 71:45-53, 2000. (Pubitemid 30440651)
35. Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52:65-70, 2003. (Pubitemid 36020767)
36. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 21:467-476, 2004. (Pubitemid 39370503)
37. Melgar S, Karlsson A, Michaëlsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 288:G1328-G1338, 2005. (Pubitemid 40741088)
38. Park JH, Lee JK, Kim HS, Chung ST, Eom JH, Kim KA, Chung SJ, Paik SY, Oh HY. Immunomodulatory effect of caffeic acid phenethyl ester in BALB/c mice. Int Immunopharmacol 4:429-436, 2004. (Pubitemid 38375975)
39. Ansorge S, Reinhold D, Lendeckel U. Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-beta1 production of human immune cells. Z Naturforsch [C] 58:580-589, 2003. (Pubitemid 36971463)
40. Baer BR, Rettie AE. CYP4B1: an enigmatic P450 at the interface between xenobiotic and endobiotic metabolism. Drug Metab Rev 38: 451-476, 2006. (Pubitemid 44167198)
41. Ding X, Kaminsky LS. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol 43:149-173, 2003. (Pubitemid 37372638)
42. Renton KW. Cytochrome P450 regulation and drug biotransformation during inflammation and infection. Curr Drug Metab 5:235-243, 2004. (Pubitemid 38735778)
43. Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman JB. Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. Arch Biochem Biophys 436:50-61, 2005. (Pubitemid 40332424)
44. McKinnon RA, Burgess WM, Gonzalez FJ, Gasser R, McManus ME. Species-specific expression of CYP4B1 in rabbit and human gastrointestinal tissues. Pharmacogenetics 4:260-270, 1994. (Pubitemid 24337434)
45. Stoilov I, Krueger W, Mankowski D, Guernsey L, Kaur A, Glynn J, Thrall RS. The cytochromes P450 (CYP) response to allergic inflammation of the lung. Arch Biochem Biophys 456:30-38, 2006. (Pubitemid 44820025)
46. Rainov NG, Dobberstein KU, Sena-Esteves M, Herrlinger U, Kramm CM, Philpot RM, Hilton J, Chiocca EA, Breakefield XO. New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2- aminoanthracene/4-ipomeanol. Hum Gene Ther 9:1261-1273, 1998. (Pubitemid 28312891)
47. Frank S, Steffens S, Fischer U, Tlolko A, Rainov NG, Kramm CM. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy. Cancer Gene Ther 9:178-188, 2002. (Pubitemid 34141921)
48. Mohr L, Rainov NG, Mohr UG, Wands JR. Rabbit cytochrome P450 4B1: a novel prodrug activating gene for pharmacogene therapy of hepatocellular carcinoma. Cancer Gene Ther 7:1008-1014, 2000. (Pubitemid 30483480)
49. Iber H, Chen Q, Morgan ET. Suppression of CYP2C11 gene transcription by interleukin-1 mediated by NFjB binding at the transcription start site. Arch Biochem Biophys 377:187-194, 2000. (Pubitemid 30257304)
50. Tinel M, Elkahwaji J, Robin MA, Fardel N, Descatoire V, Haouzi D, Berson A, Pessayre D. Interleukin-2 overexpresses c-myc and downregulates cytochrome P-450 in rat hepatocytes. J Pharmacol Exp Ther 289:649-655, 1999. (Pubitemid 29191214)
51. Gu X, Ke S, Liu D, Sheng T, Thomas PE, Rabson AB, Gallo MA, Xie W, Tian Y. Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem 281:17882-17889, 2006. (Pubitemid 44035587)
52. Khatsenko OG, Boobis AR, Gross SS. Evidence for nitric oxide participation in down-regulation of CYP2B1/2 gene expression at the pretranslational level. Toxicol Lett 90:207-216, 1997. (Pubitemid 27096536)
53. Takemura S, Minamiyama Y, Imaoka S, Funae Y, Hirohashi K, Inoue M, Kinoshita H. Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia. J Hepatol 30:1035-1044, 1999. (Pubitemid 29278747)
54. Atik E, Gorur S, Kiper AN. The effect of caffeic acid phenethyl ester (CAPE) on histopathological changes in testicular ischemia-reperfusion injury. Pharmacol Res 54:293-297, 2006. (Pubitemid 44233333)
55. Song YS, Park EH, Hur GM, Ryu YS, Lee YS, Lee JY, Kim YM, Jin C. Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity. Cancer Lett 175:53-61, 2002. (Pubitemid 33153044)